2B78D Stock Overview
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$6.73 |
52 Week High | US$7.18 |
52 Week Low | US$6.67 |
Beta | 0 |
1 Month Change | -6.27% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 1.97% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
2B78D | GB Capital Markets | GB Market | |
---|---|---|---|
7D | -0.4% | 1.2% | 2.8% |
1Y | n/a | 5.8% | 1.1% |
Return vs Industry: Insufficient data to determine how 2B78D performed against the UK Capital Markets industry.
Return vs Market: Insufficient data to determine how 2B78D performed against the UK Market.
Price Volatility
2B78D volatility | |
---|---|
2B78D Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 4.3% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 11.3% |
10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 2B78D has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 2B78D's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | n/a | n/a | www.ishares.com/uk/institutional/en/products/284216/HEAL |
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. The fund is managed by BlackRock Advisors (UK) Limited. It invests in public equity markets across the globe.
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF Fundamentals Summary
2B78D fundamental statistics | |
---|---|
Market cap | €967.18m |
Earnings (TTM) | €0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs 2B78D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2B78D income statement (TTM) | |
---|---|
Revenue | €0 |
Cost of Revenue | €0 |
Gross Profit | €0 |
Other Expenses | €0 |
Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did 2B78D perform over the long term?
See historical performance and comparison